Cargando…
Pulmonary Manifestations of Vasculitis
Respiratory manifestations in patients with a primary systemic vasculitis syndrome need to be separated into those caused by the vasculitis itself, those related to treatment complications, and those caused by unrelated or only indirectly related comorbidities such as obstructive sleep apnea. Respir...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120293/ http://dx.doi.org/10.1007/978-1-4939-0770-0_10 |
_version_ | 1783514941279436800 |
---|---|
author | Specks, Ulrich |
author_facet | Specks, Ulrich |
author_sort | Specks, Ulrich |
collection | PubMed |
description | Respiratory manifestations in patients with a primary systemic vasculitis syndrome need to be separated into those caused by the vasculitis itself, those related to treatment complications, and those caused by unrelated or only indirectly related comorbidities such as obstructive sleep apnea. Respiratory tract involvement is most common in the ANCA-associated vasculitides. Respiratory manifestations are less frequent and less prominent in other forms of systemic vasculitis, but they may nevertheless represent significant management challenges and carry a poor prognosis. This chapter reviews the tracheobronchial and pulmonary parenchymal disease manifestations, their clinical presentation, and differential diagnosis for each of the vasculitis syndromes. A systematic differential diagnostic approach to the patient with diffuse alveolar hemorrhage is also provided. |
format | Online Article Text |
id | pubmed-7120293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71202932020-04-06 Pulmonary Manifestations of Vasculitis Specks, Ulrich Pulmonary Manifestations of Rheumatic Disease Article Respiratory manifestations in patients with a primary systemic vasculitis syndrome need to be separated into those caused by the vasculitis itself, those related to treatment complications, and those caused by unrelated or only indirectly related comorbidities such as obstructive sleep apnea. Respiratory tract involvement is most common in the ANCA-associated vasculitides. Respiratory manifestations are less frequent and less prominent in other forms of systemic vasculitis, but they may nevertheless represent significant management challenges and carry a poor prognosis. This chapter reviews the tracheobronchial and pulmonary parenchymal disease manifestations, their clinical presentation, and differential diagnosis for each of the vasculitis syndromes. A systematic differential diagnostic approach to the patient with diffuse alveolar hemorrhage is also provided. 2014-05-05 /pmc/articles/PMC7120293/ http://dx.doi.org/10.1007/978-1-4939-0770-0_10 Text en © Springer Science+Business Media New York 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Specks, Ulrich Pulmonary Manifestations of Vasculitis |
title | Pulmonary Manifestations of Vasculitis |
title_full | Pulmonary Manifestations of Vasculitis |
title_fullStr | Pulmonary Manifestations of Vasculitis |
title_full_unstemmed | Pulmonary Manifestations of Vasculitis |
title_short | Pulmonary Manifestations of Vasculitis |
title_sort | pulmonary manifestations of vasculitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120293/ http://dx.doi.org/10.1007/978-1-4939-0770-0_10 |
work_keys_str_mv | AT specksulrich pulmonarymanifestationsofvasculitis |